Stephen Green has served as Transluminal’s President since May 2013. Prior to being appointed as president, Mr. Green served as Vice President, Research & Development of the company. Mr. Green is a 30-year veteran of medical device design and is an inventor in over 20 US and international patents. In 1989, Mr. Green founded Stephen Green Engineering Associates, a Syracuse, New York-based technical consulting firm specializing in bio-mechanical systems design. Mr. Green’s firm has developed products for a wide range of medical device markets including respiratory therapy, endo-surgery, orthopedic surgery, neurosurgery, endoscopy, and electro-cardio diagnostics.

Ronald Caputo, MD has served as Transluminal’s Medical Director since its inception. Dr. Caputo is the Director of Cardiology at St. Joseph’s Hospital and Assistant Clinical Professor of Medicine at SUNY-HSC, both facilities located in Syracuse, New York. Dr. Caputo is the author of over 50 peer reviewed scientific publications in the specialty of Interventional Cardiology. In 1999, Dr. Caputo co-founded Angiolink Corporation, a Massachusetts-based privately-held medical device company focused on developing innovative wound closure solutions for vascular procedures. Medtronic, Inc. (NYSE: MDT) acquired Angiolink in November 2014.

$25.16 BN Market

Unhealthy lifestyle habits such as high alcohol consumption, smoking, and lack of physical exercise are triggering incidences of cardiovascular diseases.

Transluminal Technologies Attends TCT, Announces Innovative Velox CD